Dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in cardiovascular disease
Zhenhua Huang
Abstract
Zhenhua Huang
Abstract
The dual inhibitor of angiotensin converting enzyme and neutral endopeptidase is a new type of drug in the treatment of cardiovascular disease,and proved to be more effective and more advantage than angiotensin converting enzyme inhibitor or neutral endopeptidase inhibitor alone.It plays an important role in the treatment of heart failure and hypertension.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The dual inhibitor of angiotensin converting enzyme and neutral endopeptidase is a new type of drug in the treatment of cardiovascular disease,and proved to be more effective and more advantage than angiotensin converting enzyme inhibitor or neutral endopeptidase inhibitor alone.It plays an important role in the treatment of heart failure and hypertension.
Key concepts: Neprilysin, ACE inhibitor, Angiotensin-converting enzyme, Enzyme inhibitor, Endopeptidase, Pharmacology, Enzyme, Renin–angiotensin system